5817-96-9: 5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one impurity

Status: In-stock

It is one of impurity present in Tofacitinib, Tofacitinib is an inhibitor of Janus kinases is a group of intracellular enzymes involved in signaling pathways that affect hematopoiesis and immune cell function, prevent the body from responding to cytokine signals. Tofacitinib is a partial and reversible Janus kinase inhibitor that prevents the body from responding to cytokine signals. which use is associated with a rapid decrease in C-reactive protein dose-dependent decreases in natural killer cells, and dose-dependent increases in B cells.

Additional information on CAS 5817-96-9

Catalogue No. VE0010061
CAS No. 5817-96-9
Molecular Formula C6H5N3O
Molecular Weight 135.12 g/mol
Parent drug Tofacitinib
IUPAC Name 5, 7-dihydro-6H-pyrrolo [2, 3-d] pyrimidin-6-one
Synonyms N/A
References Cada, D. J., Demaris, K., Levien, T. L., & Baker, D. E. (2013). Tofacitinib. Hospital Pharmacy, 48(5), 413–424. https://doi.org/10.1310/hpj4805-413
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

5817-96-9: 5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one impurity

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.